A combination of transcription factors, enhancers, and epigenetic marks determines the expression of the key transcription factor FoxP3 in regulatory T cells (Tregs). Adding an additional layer of complexity, the long noncoding RNA (lncRNA) Flicr (Foxp3 long intergenic noncoding RNA) is a negative regulator that tunes Foxp3 expression, resulting in a subset of Tregs with twofold-to fivefoldlower levels of FoxP3 protein. The impact of Flicr is particularly marked in conditions of IL-2 deficiency, and, conversely, IL-2 represses Flicr expression. Flicr neighbors Foxp3 in mouse and human genomes, is specifically expressed in mature Tregs, and acts only in cis. It does not affect DNA methylation, but modifies chromatin accessibility in the conserved noncoding sequence 3 (CNS3)/Accessible region 5 (AR5) region of Foxp3. Like many lncRNAs, Flicr's molecular effects are subtle, but by curtailing Treg activity, Flicr markedly promotes autoimmune diabetes and, conversely, restrains antiviral responses. This mechanism of FoxP3 control may allow escape from dominant Treg control during infection or cancer, at the cost of heightened autoimmunity.
A combination of transcription factors, enhancers, and epigenetic marks determines the expression of the key transcription factor FoxP3 in regulatory T cells (Tregs) . Adding an additional layer of complexity, the long noncoding RNA (lncRNA) Flicr (Foxp3 long intergenic noncoding RNA) is a negative regulator that tunes Foxp3 expression, resulting in a subset of Tregs with twofold-to fivefoldlower levels of FoxP3 protein. The impact of Flicr is particularly marked in conditions of IL-2 deficiency, and, conversely, IL-2 represses Flicr expression. Flicr neighbors Foxp3 in mouse and human genomes, is specifically expressed in mature Tregs, and acts only in cis. It does not affect DNA methylation, but modifies chromatin accessibility in the conserved noncoding sequence 3 (CNS3)/Accessible region 5 (AR5) region of Foxp3. Like many lncRNAs, Flicr's molecular effects are subtle, but by curtailing Treg activity, Flicr markedly promotes autoimmune diabetes and, conversely, restrains antiviral responses. This mechanism of FoxP3 control may allow escape from dominant Treg control during infection or cancer, at the cost of heightened autoimmunity.
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R egulatory T cells (Tregs), a subset of CD4
+ T cells determined by the transcription factor (TF) FoxP3, are fundamental actors in maintaining immune homeostasis, by dampening activation of several immunocyte lineages (1, 2) . In their absence, humans and mice develop devastating autoimmune and lymphoproliferative pathologies (3) . Although beneficial in preventing runaway immune activation, supporting tolerance of symbiotic microbes, and restraining tissue destruction in autoimmune lesions, their regulatory activity can also be deleterious, for example, by inhibiting antitumor (4) or antiviral responses (2, 5) .
Phenotypic stability is important for Tregs (1, (6) (7) (8) , particularly as their antigen receptors tend to show reactivity to self-antigens. This stability, and the stability of Foxp3 expression, result from a combination of factors (9) : DNA hypomethylation at conserved enhancer elements of Foxp3 and other key loci (10) or selfreinforcing TF networks (11) . This stability is bolstered by signals from IL-2, the key trophic cytokine for Tregs (2, 7, 9, 12, 13) . At the center of this network lies FoxP3, the lineage-defining TF that is essential for Treg differentiation, maintenance, and function (1, (14) (15) (16) (17) . Several enhancer elements, conserved across vertebrates, ensure correct Foxp3 expression, one of them [conserved noncoding sequence 2 (CNS2)] being important for the stability of Foxp3 expression (18) (19) (20) during cell division and in proinflammatory milieus.
Deep transcriptome analyses have revealed the existence of an abundant class of long noncoding RNAs (lncRNAs) (21) (22) (23) (24) . LncRNAs do not encode proteins and are longer (>200 bp) than other noncoding transcripts like microRNAs. This family represents up to 20% of mammalian transcriptomes, which also applies in Tregs (25) , and their expression is more tissue-specific than that of proteins. Evolving rapidly, they are poorly conserved evolutionarily, and only ∼10% of human lncRNAs have a clear homolog in mice (26) . lncRNAs seem to be mostly involved in regulating gene expression through several mechanisms, which are conditioned by expression levels (typically low), subcellular localization (nuclear or cytoplasmic) and position in the genome (23) . Some nuclear lncRNAs act in cis and activate or repress genes in their immediate vicinity; others have longer-range cis (e.g., Xist inactivates the entire X chromosome) (27) or trans action (Hotair and Hox genes) (28) (29) (30) . Cytoplasmic lncRNAs also can interfere with translation, have catalytic activity, or act as miRNA sponges (31) . In general, lncRNAs are thought to be modulators of expression patterns dictated by transcription regulators, although in some instances they have a dominant impact, as in the allelic inactivation of one copy of the X chromosome driven by Xist.
Relatively few lncRNAs specific to the immune system have been studied in detail in vivo, and their cumulative impact on immune functions remains largely unknown (32) . Some lncRNAs are dynamically expressed during development (33) , and others are important for granulocyte homeostasis (e.g., Morrbid regulates myeloid cell lifespan) (34) or immune effector functions (e.g., Rmrp and Th17 cell function, NeST and IFNγ expression in T cells) (35, 36) . Consequently, lncRNAs influence the immunopathology of infections (NeST, Morrbid), endotoxic shock (lincRNA-EPS) (37) , or gut inflammatory diseases (Rmrp, linc-13) (36, 38) .
While analyzing lncRNA expression in Treg profiling data, we noticed the transcript 4930524L23Rik. Its Treg-specific expression and genomic localization, partially overlapping Foxp3, were too striking to ignore. Here we report the structure, expression, and function of this lncRNA, hereinafter called Flicr (Foxp3 long intergenic noncoding RNA). This lncRNA is present across mammalian species with clear stretches of sequence conservation. Flicr modulates Foxp3 expression, most visibly in a subset of Tregs. This subtle fine-tuning has important consequences for autoimmune disease, thus subtly modulating the Janus-faced dominant suppressive function of Tregs.
Significance
Regulatory T cells (Tregs) are an essential population of immunoregulatory cells that play a central role in immune tolerance and the control of autoimmune disease, infections, and cancer. The transcription factor FoxP3 is the central orchestrator of Treg differentiation, stability, and function. Here we report the discovery of the noncoding RNA, Flicr, and its finetuning of FoxP3 expression through modification of chromatin accessibility, with marked consequences on the progression of autoimmune diabetes. Our findings add an important piece to the puzzle of Treg differentiation and stability, and how their function adapts to physiological circumstances.
Results
Flicr, an lncRNA Specifically Expressed in Tregs. Flicr first caught our attention as an lncRNA detected only in Tregs among the ImmGen compendium of immunocyte gene expression (39) (Fig. 1A) . This exclusivity was confirmed by RNA sequencing (RNA-Seq) analysis (Fig. S1) . Outside of the immune system, Flicr was observed only in the testis, at low levels (40) (Fig. 1B) . During Treg differentiation, it appeared concomitantly with Foxp3 but only in the final CD25 hi stage (Fig. 1C) . Flicr was present in Tregs from all peripheral lymphoid organs and at lower levels in the specific Treg populations found in several nonlymphoid tissues (Fig. 1D) . Tissue Tregs tend to have activated phenotypes and, accordingly, Treg activation slightly reduced Flicr expression in vivo (41) and in vitro (42) (Fig. 1E) . In contrast, Flicr was not expressed in induced Tregs generated in vitro from naïve conventional T cells (Tconvs) with TGF-β and IL-2 (43) (Fig. 1F) . That Flicr expression may require thymic Treg differentiation was consistent with its lower abundance in colonic RORγ + Helios − Tregs, considered to result from extrathymic differentiation, relative to their thymically derived RORγ 
Helios
+ counterparts (44) (Fig. 1G ). In keeping with the notion that FoxP3 alone is not sufficient to promote Flicr expression, transduction of Foxp3 in CD4
+ T cells did not induce Flicr (11) (Fig. 1H ).
However, FoxP3 was necessary for Flicr expression, because Treglike cells, in which Foxp3 is transcriptionally active but encodes a nonfunctional protein, were Flicr-negative (45) (Fig. 1I ).
Structure and Conservation of the Mouse and Human FLICR. We combined several types of analyses and external data sources to accurately position Flicr transcripts in the mouse genome ( Fig.  2A) , identifying four different isoforms of varying lengths (566, 737, 3,278, and 4,150 bp) that share two exonic elements and an intron, located 1.8 kb upstream of the Foxp3 transcriptional start site (TSS). They are all transcribed from the same sense strand of ChrX as Foxp3, and the two longest ones overlap the Foxp3 TSS. A 5′ rapid amplification of cDNA ends (RACE) analysis mapped several closely spaced 5′ ends of Flicr transcripts, concordant with CAGE data from the FANTOM Consortium (46) (Fig.  S2A ). However, we could not find evidence in Tregs for transcripts initiating further upstream and corresponding to the 4930524L23Rik or Ppp1r3fos expressed sequence tags (ESTs) previously isolated from testis and thymus. A combination of 3′ RACE and polyA-tagged RNA-Seq data identified three main polyadenylation sites ( Fig. 2A and Fig. S2A ). These transcripts contained no open reading-frame (ORF) longer than 143 aa, and 
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In vitro activation
In vivo activation had computationally predicted low peptide coding potential by codon substitution frequency analysis (PhyloCSF) (47); however, as for most lncRNAs, the possibility of translation into very short peptides cannot be ruled out (Fig. S2C) . lncRNAs are usually poorly conserved, but the region common to mouse Flicr isoforms showed distinct sequence homology to a similar location upstream of human FOXP3 ( Fig. 2A ) and more generally among placental mammals. Indeed, focused PCR identified three FLICR isoforms in the human FOXP3 + C5/MJ cell line, structures that were confirmed by parsing RNA-Seq from human Tregs (48) . The main 5′ ends mapped closer to PPP1R3F than in the mouse, and we did not find FLICR transcripts that overlapped the FOXP3 TSS, but the intron and flanking exons were again found ∼2 kb upstream of FOXP3 ( Fig.  2A and Fig. S2B ). There was no preservation of putative ORFs in the conserved region, with nonsense or frame shift mutations in all possible reading frames (Fig. S2C) . As in the mouse, FLICR expression was restricted to Tregs ( Fig. 2B ; human RNA-Seq) (48) . Thus, human and mouse Tregs specifically express an lncRNA of very similar structure and position, situated very close to the Foxp3 locus.
Flicr Dampens FoxP3 Expression in Tregs. To determine its function, we generated a Flicr-deficient mouse line by deleting a short segment (263 bp) encompassing exon 2 and the splice junction, the focal point of sequence conservation (Fig. 3A) , using CRISPR/ Cas9 (clustered regularly interspaced short palindromic repeats) to introduce two specific breaks for nonhomologous end-joining in fertilized mouse eggs (49) . We purposely kept the deletion very short to avoid affecting Foxp3 enhancer elements, targeting a region devoid of H3K27Ac enhancer, H3K27me3 repressive marks, or CpG islands (Fig. S3A) (50) . Indeed, transcriptome analysis showed that Tregs in Flicr-deficient (KO) mice lost Flicr, but not Ppp1r3f and Foxp3 transcripts, the latter being slightly increased (Fig. 3B) . KO mice developed and grew normally, with no histological evidence of systemic autoimmune disease. Treg differentiation and homeostasis seemed unchanged, with normal Treg proportions in the thymus, spleen, and lymph nodes (Fig. S3B) ; however, close examination of cytometry profiles revealed a consistent trait (Fig. 3C ): whereas CD25
hi Tregs from WT mice showed the usual range of FoxP3 expression, with some cells having twofold to fivefold less FoxP3 than the main peak, Flicrdeficient Tregs had a tighter distribution, with significantly fewer FoxP3 lo Tregs. Correspondingly, the overall mean fluorescence intensity (MFI) increased slightly (Fig. 3D ). This disappearance of the FoxP3 lo Tregs was observed in Flicr-deficient mice on the NOD background, where the mutation was initially constructed, and on the autoimmune-resistant B6xNOD background (Fig. S3C) .
Although the Flicr KO deletion was relatively small (263 bp) and eschewed regulatory regions identifiable by chromatin marks, we wanted to assess definitively whether these observations could be explained by the deletion of a putative regulatory DNA element. First, the same reduction of FoxP3 lo cells was present in an independent Flicr mutant mouse in which only 12 bp at the splice junction of exon 3 were deleted ( Fig. 3A and Fig. S3D ). Unfortunately, only one progeny could be obtained from this line, precluding statistical analysis and follow-up, but nevertheless this provides confirmatory evidence. Second, we confirmed the results by an independent RNAi approach, transfecting locked nucleic acid (LNA) antisense oligonucleotide to target Flicr in Tregs in culture (34) . Here again, a reduction in FoxP3 lo cells was observed ( Fig. 3E) , confirming a direct role of Flicr RNA on FoxP3 expression. Third, if Flicr down-regulates FoxP3 in a subset of cells, then it would be predicted to be overrepresented in FoxP3 lo cells. Indeed, more Flicr RNA was detected in cells with lower FoxP3 (Fig. 3F) .
To test whether the FoxP3 phenotype of Flicr-deficient mice was Treg-autonomous or resulted from an indirect effect, we constructed mixed chimeras. Alymphoid Rag-deficient hosts were reconstituted with equal proportions of bone marrow from Flicr WT and KO donors. In this setting, we again observed the "tightening" of FoxP3 expression in Tregs of Flicr KO genotype, relative to WT Tregs in the same hosts ( Fig. 4A) , indicating a Treg-intrinsic effect. Interestingly, KO Tregs had a competitive advantage over their WT counterparts in the same mice; the ratio of cells of KO vs. WT origin was consistently higher in Tregs than in CD4 + Tconvs in the same mice (Fig. 4B , Left), which resulted in a higher proportion of Tregs in the KO pool ( Fig. 4B) , revealing better fitness of Flicr-deficient Tregs than was observed in the full KO mice.
Flicr Destabilizes FoxP3 Expression in Conditions of Limiting IL-2. The foregoing results suggested that Flicr affects the stability of FoxP3 expression in some Tregs. For confirmation, we cultured Tregs in conditions of limited IL-2, under which FoxP3 tends to be lost (51) . The FoxP3 lo cells that normally appear in low-IL-2 cultures were essentially absent in Treg cultures from Flicr-deficient mice (Fig. 5A) . Thus, the subtle effect observed under steady state was magnified when trophic support became limiting.
These results also suggested that IL-2 and Flicr are diametric opposites with regard to Treg homeostasis. Because IL-2 signaling stabilizes FoxP3 expression by recruiting the transcription factor STAT5b to the Foxp3 locus (52), we hypothesized that it might inhibit Flicr to maintain Foxp3 expression. Indeed, provision of IL-2 lowered Flicr expression in culture (Fig. 5B) . Interestingly, a slight accumulation of STAT5b was present in the FLICR promoter region in a ChIP sequencing analysis of human Tregs (53) (Fig. 5C ), suggesting a pathway by which IL-2 might repress Flicr directly. Thus, Flicr appeared to be an active mechanism of Foxp3 destabilization, which IL-2 counteracts.
Flicr Acts only in Cis. PCR quantitation after nuclear-cytoplasmic fractionation showed that Flicr, like Xist, resides primarily in the nucleus (Fig. S4A ), suggesting that it might regulate transcription. We asked whether Flicr had broader effects in Tregs beyond its cis action on the neighboring ), and the transcripts most affected by the deletion of Flicr were Treg signature genes (Fig. 6B) . Similarly, FoxP3-binding genomic targets (ChIP sequencing data from ref. 54) were mostly underexpressed in WT Tregs compared with KO Tregs (Fig. 6C ). These findings suggest that many/most of Flicr's effects result from lowering or destabilization of Foxp3 expression.
Given its position, Flicr seemed likely to influence Foxp3 transcription through a local cis effect, as is the case for several lncRNAs (27, 30, 55) . We tested this hypothesis by attempting to complement Flicr KO mice with a BAC transgene that includes a WT Flicr, together with an insertionally inactivated Foxp3 (56) (Fig. 6D) . Although the transgene-encoded Flicr was expressed at the same level as the endogenous one (Fig. S4B) , it did not restore FoxP3 lo Tregs in vivo (Fig. 6E) or the sensitivity to low IL-2 supply in vitro (Fig. 6F) . Expression of the genes affected by the Flicr deficiency also was not normalized by the Flicr-encoding complementing transgene (Fig. S4B) , reinforcing the notion that Flicr's influence on their expression is indirect, via FoxP3. Thus, Flicr's genomic proximity to Foxp3 is necessary for its mechanism of action. These results show that Flicr is a nuclear lncRNA that acts in cis on Foxp3 expression, and indirectly has a subtle but broader impact on the Treg transcriptome.
Flicr Influences Focal Chromatin Accessibility in the Foxp3 Locus.
Given that Flicr acts in cis, we reasoned that it might influence the Foxp3 epigenetic landscape. Methylation at several CpG clusters within the Foxp3 locus, particularly in the CNS2 enhancer region, correlates with the stability of its expression (10, 57) . However, comparison of methylation at the Foxp3 locus in Flicr WT and KO Tregs showed superimposable profiles, except for a minor alteration within Flicr itself (Fig. 7A) . Treg-specific hypomethylation at CNS2 was intact.
We then used assay for transposase-accessible chromatin (ATAC) high-throughput sequencing (ATAC-seq), which probes chromatin openness by its accessibility to the Tn5 transposase, and produces detailed information on the configuration of hypersensitive TSS and enhancer elements (58) . Six accessible regions were identifiable across Foxp3 in Tregs: the promoter, the CNS2 and CNS3 enhancers (20) , two other regions [hereinafter referred to as accessible regions (AR) 5 and 6], and the 3′ UTR (Fig. 7B) . Overall, ATAC-seq profiles were very similar in Flicr WT and KO Tregs, but close examination revealed reciprocal shifts at Accessible region 5 (AR5) [less accessible in KO Tregs; P = 0.03 based on the genome-wide variance distribution between replicates (DiffBind)] (Fig. 7B) and CNS3 (more accessible; P = 0.01). These shifts were reproducible in independent experiments, as was the increased accessibility in the 3′ UTR, possibly reflecting altered Pol-II recycling. In contrast, CNS2 profiles did not vary.
Physiological Consequences of Flicr Deletion. FoxP3 stability is needed to maintain Treg homeostasis and prevent autoimmunity (6) . An active mechanism that destabilized Foxp3 expression in Tregs might be advantageous as a "back door" to avoid dominant Treg control in some circumstances, but also seems risky. We tested immune function in Flicr-deficient mice in several Tregdependent settings. A first set of experiments showed identical growth of the MC38 tumor line in Flicr WT and KO hosts. We then tested the notion that Flicr might promote autoimmunity by destabilizing Treg function (8, 56) , and analyzed the course of autoimmune diabetes in Flicr-deficient NOD females. These mice showed a significantly reduced rate and incidence of overt diabetes (Fig. 8A ). This halving of diabetes incidence was reflected in reduced severity of insulitis at age 11 wk (Fig. 8B) . In the inflammatory context of these infiltrated islets (Fig. 8C) , Tregs showed the same stabilization of FoxP3 levels in the absence of Flicr as they did in lymphoid organs. As reported previously (59), insulitis was inversely correlated with the proportion of Treg in the pancreas (Fig. 8D) . Interestingly, the slope of this anticorrelation was steeper in Flicr KO mice than in heterozygous or WT control littermates (r = −0.91 vs. r = −0.46; P = 0.05), possibly suggesting that Flicr-deficient Tregs are functionally more efficient on a percell basis, reminiscent of the superior fitness noted above.
Discussion
Here we report the discovery of the lncRNA Flicr, a negative regulator of Foxp3 expression in Tregs. It appears to act exclusively in cis, but by controlling FoxP3 has wider effects on the specific Treg transcriptome and Treg fitness. Its molecular effects are subtle, and more particularly visible in a subset of Tregs, but they have a marked impact on the efficacy of peripheral immunologic tolerance. The Foxp3 locus appears to come directly equipped with a counterregulatory mechanism. Based on its genomic location, expression pattern, and physiological impact, Flicr seems to be one of the lncRNAs that selectively modulates a specific physiological function, here Treg activity. FoxP3 does not merely obey on/off regulation to dictate Treg repressive functions, but can be tuned in response to different environmental cues, particularly in conditions of limiting IL-2 (2, 4, 18, 19). These results show that IL-2 has two means of enhancing Foxp3 expression, directly via activation of the Cns2 enhancer and indirectly by repressing Flicr, the attenuator of Foxp3. Flicr expression is also curtailed in conditions of heightened Treg activation and functionality, in tissue Tregs and after TCR activation. By destabilizing Foxp3, Flicr dampens the Treg signature and may lower Treg stability, allowing stronger antiviral responses but also increasing the risk of as autoimmune disease.
Like other lncRNAs in the immune system (60), Flicr has a focused role that matches its expression. In this respect, it contrasts with Rmrp, the impact of which in T lymphocytes seems limited to Th17 cells despite ubiquitous expression (36) , but is akin in this respect to Morrbid (34) and NeST (35) , which have a range of activity conditioned by their restricted expression. From the lack of trans complementation by the Flicr-expressing BAC transgene, we infer that the mild bias that it imparts on other loci, predominantly Treg signature genes, is indirectly due to FoxP3 dampening. Several of these Treg signature genes are related to the different mechanisms through which Treg cells exert their suppressive activity (61) . Thus, modification of the stability of FoxP3 expression and shifts in Treg signature genes likely contribute to the down-modulation of Treg function and fitness by Flicr. Importantly, Flicr seems to preferentially impact a subset of Tregs; increased FoxP3 levels are seen not in the main Treg pool, in which mean FoxP3 levels are not noticeably affected, but rather in the FoxP3 lo subset. We speculate that in vivo FoxP3 lo Tregs are equivalent to those observed in vitro when IL-2 is limiting, and that Flicr may be hastening their shutdown of FoxP3 expression.
Cis-acting lncRNAs have several modes of action (30) . The localized human/mouse sequence conservation suggests that it is not akin to lncRNAs, the very transcription of which is regulatory by promoter interference, but that the primary or secondary structure of the RNA matters (30) , possibly involving the splicing machinery given that the sequence conservation extends into the intron. Like many other lncRNAs, Flicr's molecular signature is subtle, but ultimately results in a larger shift in the outcome of pancreatic autoimmunity and the progression to overt diabetes. This amplification is congruent with the observation that many of the genetic variants (eQTLs) that condition the propensity to autoimmune disease have only subtle effects on the expression of the gene that they influence. Because much of lymphocyte differentiation is related to engagement by self molecules, the immune system is likely tuned at the edge of autoimmunity, and small changes, here in Treg fitness, can tip the system toward serious autoimmune consequences. Different mechanisms are involved in controlling the stability of Foxp3 expression. At the epigenetic level, the CNS2 enhancer plays a critical role, reinforced by DNA methylation (10) , and by integrating signals from the TCR and the IL-2 receptor (18, 19) . However, Flicr does not seem to influence DNA methylation or chromatin accessibility at CNS2, but instead affects chromatin structure in the CNS3/AR5 region. CNS3 previously has been described as a poised enhancer open more generally in the T-cell lineage and important for Treg differentiation (41) . Our results suggest this region also has a role in mature Tregs, balanced with AR5. lncRNAs commonly operate within ribonucleoprotein complexes with specific TFs (36), chromatin modifiers (28), or Hnrnp proteins (37, 60) , and we propose that Flicr may target a repressive complex to the CNS3/AR5 region of Foxp3.
The functions of lncRNAs in the immune system are just being elucidated. Through its effects on Tregs, FLICR may be associated with human diseases associated with enhanced Treg activity, like infections or tumors, and its modulation opens avenues to suppress or enhance Treg function.
Materials and Methods
All experimental procedures are described in detail in SI Materials and Methods.
Mice. C57BL/6J mice were obtained from The Jackson Laboratory. NOD/Lt/DOI and Foxp3-DTR-GFP/N (56), Foxp3-Ires-Thy1.1/B6 (62), and Foxp3-IRES-GFP/B6 (63) mice were maintained in our colony. Foxp3-DTR-GFP/N carries a BAC transgene encompassing 150 kb downstream and 70 kb upstream of the Foxp3 TSS, with a DTR-eGFP-stop insertion between the first and second codons of Foxp3. All experimentation was performed following animal protocol guidelines of Harvard Medical School (reviewed and approved HMS IACUC protocols 02954). and 5′ RACE were performed using the SMARTer RACE cDNA Amplification Kit (Clontech), followed by Sanger sequencing. The 3′ termini were also mapped using RNA-Seq, and 5′ extremities were mapped from the FANTOM CAGE data (46) . Exploratory PCR was performed using primers spanning the 4930524L23Rik locus, as shown in Flicr KO Mice. To generate Flicr-deficient mice using the CRISPR/Cas9 system, we closely followed the method of Yang et al. (49) with several modifications. Because the active region of Flicr is unknown, we chose to introduce a point mutation using one guide RNA (gRNA) targeting the shared splice donor site or to delete a whole exon (exon 2) using two gRNAs, encompassing the region of highest homology between mouse and human transcripts, but keeping the mutation as small as possible to avoid interfering with Foxp3 enhancer elements. Two mutants were obtained. One founder had a 12-bp deletion deleting the donor spliced site of exon 3, but gave only one progeny. Another mutant had a 263-bp deletion spanning Flicr exon 2.
Mapping of Mouse and Human
In Vitro FoxP3 Stability. CD4 + T cells from spleen and subcutaneous lymph nodes isolated by magnetic negative selection and CD4 + TCRβ + CD25 hi (top 50%) Tregs were sorted by flow cytometry, then cultured with anti-CD3/ CD28 beads (1:1 bead:cell; Gibco) and IL-2 (Peprotech; 212-12).
Gene Expression Profiling by Microarray. Microarray preparation and analysis were performed in accordance with ImmGen protocols (39) . In brief, 50,000 CD4 + TCRβ + CD25 hi (top 50%) Tregs and CD25 − Tconvs isolated from pooled spleen and subcutaneous lymph nodes from 8-wk-old Flicr WT and KO mice were double-sorted as above. RNA was prepared from TRIzol extracts and used to prepare probes for Affymetrix Mouse Gene 1.0 ST arrays. Gene expression differences were calculated using the lmFit and eBayes functions of the limma package (64).
ATAC-seq. ATAC-seq was performed in biological duplicates following the protocol described by Buenrostro et al. (58) . In brief, 50,000 CD4
(top 50%) Tregs were sorted and lysed. After transposition and PCR, final bead purification and selection (100-600 bp) were performed twice using 0.6× and 1.6× solid phase reversible immobilization (SPRI) beads. Libraries were pairedend sequenced (40, 50) using a 75-bp kit on an Illumina NextSeq HighThroughput Sequencing System. Reads were filtered for quality and adapter-trimmed before mapping to the mm9 mouse genome. Reads mapping to multiple positions and PCR duplicates were discarded. Nucleosome free fragments (<120 bp) were analyzed, and peaks were called using Homer (65) . Data were imported in R, and differential peak analysis was performed using DiffBind (differential peak analysis based on negative binomial distributions) (66) .
Methylation Analysis by Bisulfite Treatment and High-Throughput Sequencing.
The protocol was adapted from Feng et al. (18) . Here 80,000 CD25 hi Tregs were sorted as above, and DNA was purified and bisulfite-converted using the EZ DNA Methylation Direct Kit (Zymo Research), amplified by PCR. Illumina adapters were ligated and libraries amplified by a final PCR before sequencing using an Illumina MiSeq system. Reads were trimmed of the adapter aligned to the mm9 genome using Bismark (67) . Data were analyzed and visualized using custom R scripts and the BiSeq library (68).
Autoimmune Diabetes. For diabetes incidence, mice were screened for diabetes by glucose urinalysis every week for 30 wk. A positive strip test was confirmed by blood analysis, and animals were considered diabetic with glucose >250 mg/dL on 2 consecutive days. For histological evaluation, formalin-fixed and paraffin-embedded pancreas was sectioned and stained with hematoxylin and eosin. Four steps sections separated by 100 μm were used to calculate the insulitis score for each islet cells (0, no infiltration; 1, peri-insulitis; 2, intraislet insulitis), and 100 independent islets were scored for each mouse.
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SI Materials and Methods
Mice. C57BL/6J mice were obtained from The Jackson Laboratory. NOD/Lt/DOI and Foxp3-DTR-GFP/N (56), Foxp3-Ires-Thy1.1/B6 (62), and Foxp3-IRES-GFP/B6 (63) mice were maintained in our colony. Foxp3-DTR-GFP/N mice carry a BAC transgene encompassing 150 kb downstream and 70 kb upstream of the Foxp3 TSS. DTR-eGFP with a stop codon was inserted between the first and second codons of Foxp3. All experimentation was performed following animal protocol guidelines of Harvard Medical School (reviewed and approved HMS IACUC protocols 02954).
Flow Cytometry. Single-cell suspensions from lymphoid organs were generated by physical dissociation through a 40-μm cell strainer (Falcon). Red blood cells were lysed with ACK lysing buffer (Lonza) for 2 min on ice. For pancreas-infiltrating cells, mice were perfused before harvest via injection of ∼10 mL of PBS into the heart. Careful inspection ensured removal of visible lymph nodes. The pancreas was minced in small pieces in 500 μL of digestion buffer [DMEM-2% FBS + collagenase IV 1 mg/mL (Gibco; 17104-019) and DNase1 10 U/mL (Sigma-Aldrich; DN25)] and digested in 25 mL of digestion buffer at 37°C for 20 min at 500 × g. After filtering through a 10-μm cell strainer (Falcon), cold medium (DMEM-2% FBS) was added, and then cells were pelleted by centrifugation at 500 × g for 15 min. ACK lysis (500 μL) was performed for 1 min on ice, followed by filtration through a 50-μm cell strainer, washing for 5 min at 500 × g, and resuspension in 200 μL of PBS (DMEM-2% FBS). Cells were stained on ice for 5-10 min in the dark in FACS buffer (DMEM without phenol red-2% FBS) with antibodies against CD4 (GK1.5; BioLegend), CD25 (PC61; BioLegend), TCRβ and (H57-597; BioLegend). Foxp3 staining was performed in accordance with the manufacturer's protocol with an anti-Foxp3 mAb (FJK-16S; eBiosciences). Permeabilization and staining were done at room temperature for 30 min.
Antibody staining was performed for 20 min at 4°C in PBS with the following antibodies (1/200 dilution unless noted otherwise): CD45 (PB, clone 30-F11; BioLegend), TCRβ (PE-Cy7, clone H57-597; BioLegend), CD25 (FITC, clone PC61; eBioSciences), CD4 (V500, clone RM4.5; BD Biosciences), CD8 (PE, clone 53-6.7; BioLegend), and LiveDead Fixable Near IR (1/1000; Life Technologies). After permeabilization/fixation for 2 h on ice, Foxp3 staining (APC, clone FJK-16S; eBiosciences) was performed for 30 min at room temperature in the dark in accordance with the manufacturer's instructions.
Data were recorded on an LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo version 9.3.2. Foxp3 MFI was calculated using a FlowJo internal function. The percentage of Foxp3-low cells was calculated as the proportion of cells with 50% Foxp3 expression compared with the average normalized to CD25 expression, as shown in the gates.
Mapping of Mouse Flicr Transcripts. We performed 5′ RACE using the SMARTer RACE cDNA Amplification Kit, and Sangersequenced the product. The 5′ extremities were also confirmed with FANTOM CAGE data (46) . The 3′ termini were mapped by 3′ RACE and 3′ end RNA-Seq. Exploratory PCR was performed using primers spanning the 4930524L23Rik locus (Fig.  S2 ). Isoforms were cloned with primers designed based on the extremities found. PhyloCSF (47) We performed 5′ and 3′ RACE using the SMARTer RACE cDNA Amplification Kit (Clontech). cDNA was synthesized as described in the kit using 5′ and 3′ RACE CDS primers and SMARTer IIA oligo for template switching for 5′ RACE. cDNA ends were then amplified by nested touchdown PCR. The first PCR used Universal Primer A mixed with TD_R1 = TGGCA-GCTGCGTGTCCTCGATTTGGC for the 5′ ends or TD_F1 = TGCAAAGAGGTGGTGGTGGCCATGCAG for the 3′ ends (72). In brief, first-strand cDNA synthesis was performed using a barcoded oligonucleotide primer, which included an oligodT sequence, a sample barcode, and a T7 promoter for later amplification. Second-strand cDNA synthesis was performed using the NEBNext mRNA SecondStrand Synthesis Module (New England BioLabs). After Agencourt AMPure XP bead size selection and purification, in vitro transcription was performed overnight with the MEGAshortscript T7 Transcription Kit (Ambion). The amplified RNA was fragmented using the NEBNext Magnesium RNA Fragmentation Module (New England BioLabs), purified with AMPure beads, and treated with phosphatase and T4 polynucleotide kinase before ligation with an Illumina 3′ adapter. Ligated RNA was then reversetranscribed. P5 and P7 Illumina sequences were added by PCR. Libraries were size-selected and sequenced on an Illumina HiSeq 2500 system.
Reads were filtered for quality using the FASTX toolkit, version 0.0.13 (fastq_quality_filter -v -Q 33 -q 20 -p 80). Mapping to the mm10 reference genome and transcriptome was performed using Tophat2 (73) , conserving the strand information (tophat -p 2 -librarytype fr-firststrand -read-mismatches 5 -read-gap-length 5 -readeditdist 5 -no-coverage-search -segment-length 15 -transcriptome-index). TruSeq RNA sequencing. Here 10 5 CD4
+ TCRβ + GFP + Tregs and GFP − Tconvs from 6-wk-old Foxp3-IRES-GFP/B6 mice were double-sorted in biological duplicates on a BD FACSAria II into 500 μL of TRIzol LS. RNA was extracted as follows. RNA was separated by adding 100 μL of chloroform, mixing and spinning at 12,000 × g for 15 min at 4°C. The aqueous phase containing the RNA was harvested, and 1 μL of Glycoblue (Ambion) was added. RNA was then precipitated by adding 1 volume of isopropanol, followed by incubation for 1 h at −80°C. It was then washed with 70% ethanol and resuspended in nuclease-free water.
Illumina libraries were constructed with the TruSeq RNA Sample Preparation V2 LS Kit, in accordance with the manufacturer's instructions, with two modifications. After ligation, DNA fragments were size-selected by gel electrophoresis (150-300 bp), and 17 cycles of PCR were performed using Phusion High-Fidelity PCR Master Mix with HF Buffer (Thermo Fisher Scientific). Libraries were sequenced on an Illumina HiSeq 2000 instrument. Reads were filtered for quality using the FASTX toolkit, version 0.0.13 (fastq_quality_filter -v -Q 33 -q 20 -p 80). Mapping was performed using Tophat2 (73) on the mm9 transcriptome and genome using default parameters. Exploratory PCR. RNA from 5 × 10 4 CD4 + TCRβ + GFP + Tregs from Foxp3-IRES-GFP/B6 sorted and prepared as above was used for cDNA synthesis with SuperScript II enzyme (Invitrogen) and oligodT following the manufacturer's instructions. PCR analyses were performed using primer pairs spanning the 4930524L23Rik locus, as shown in Fig. S2A . The primers were designed to encompass regions identified by RACE and RNA-Seq, as well as putative regions suggested by the ESTs or probing introns between Ppp1r3f and Foxp3. Synthesis by PCR. Primers were designed following the extremities of 3′ and 5′ ends identified by RACE and 3′ RNA-Seq, as diagramed in Fig. S2A . All primer combinations were used, and fragments resulting from successful amplification were cloned into the TOPO-TA pCR-2.1 vector (Invitrogen) and sequenced. Four isoforms of Flicr were identified in this manner ( Fig. 2A and Fig. S2A ).
Mapping of Human Flicr Transcripts. Essentially similar techniques were used to map the human FLICR transcripts, using RNA prepared from the FOXP3 + C5/MJ HTLV1-transformed cell line (ATCC CRL-8293), cultured in Iscove's modified Dulbecco's medium supplemented with 20% FBS and penicillin-streptomycin. RACE. We performed 5′ and 3′ RACE using the same protocol as described above. Nested touchdown PCR was performed with the following primers designed in the conserved DNA region between mouse and human: 5′ reaction 1: h_F2 = CACAGAGCTGGCGAGTGTGGGT-CCC for PCR1, then h_F5 = TGACCTCAGCAGGCACTCTA for PCR2 5′ reaction 2: h_F5 = TGACCTCAGCAGGCACTCTA for PCR1, then h_F3 = GGATGAGCCAATGCCGAGG for PCR2 3′ reaction: h_R5 = TCTCAGTAGCTGATGTTTATCTTG-AATT for PCR1, then h_R4 = GGTGAAGGGGTGGATC-TTGG for PCR2.
RNA-Seq. We reanalyzed the human RNA-Seq data published by Bonnal et al. (48) , using tophat2 to map the data to a custom-made transcriptome reference derived from Hg19 and supplemented with FLICR. After removing PCR duplicates using the Picard tool MarkDuplicates (picard.sourceforge.net), we obtained gene counts using htseq-count (htseq-count -f bam -r pos -s no -t exon -i gene_id -m union) (74) and a custom GTF file supplemented with FLICR annotation. Data were normalized to the length of the genes and the library size in fragments per kb per million reads using a custom R script. Synthesis by PCR. Primers were designed following the extremities of 3′ and 5′ ends identified by RACE. All primer combinations were performed by PCR and fragments were cloned in TOPO-TA pCR-2.1 (Invitrogen) and sequenced. Three isoforms of FLICR were identified with h_F2 and h_R5.
Construction of a Flicr KO Mouse. We closely followed the methods described by Yang et al. (49) to generate Flicr-deficient mice using the CRISPR/Cas9 system, with a few modifications. Because the active region of Flicr is unknown, we chose to introduce a point mutation at the shared splice donor site (Flicr mutant 1) or to delete a whole exon (exon 2) encompassing the region of highest homology between mouse and human transcripts, but keeping the mutation as small as possible to avoid interfering with Foxp3 enhancer elements (Flicr mutant 2). (46); primers used for exploratory PCRs designed to encompass regions identified by RACE and RNA-Seq but also putative regions suggested by the ESTs or probing introns between Ppp1r3f and Foxp3; 5′ RACE fragments; 3′ RACE fragments and 3′ RNA-Seq reads; mammalian conservation (PhyloP) (69) . (B) Map of Flicr in the human genome (hg19 coordinates). From top to bottom: Refseq annotation; primers used in exploratory PCRs designed to encompass regions identified by RACE but also probing introns between PPP1R3F and FOXP3; PCR clones of Flicr isoforms; 5′ RACE fragments; 3′ RACE fragments. (C) Map of Flicr in the mouse (blue) and human (green) FOXP3 loci (mm9 and hg19 coordinates), shown at three different levels of resolution, with PhastCons placental mammal sequence conservation score (69) . At the bottom is the alignment of mouse and human transcripts in the conserved region of exons 2 and 3 and translation in the three frames. Although this region is conserved across placental mammals (red bases or amino acids), we did not find any conserved peptide sequences between human and mouse in any of the three frames, arguing against purified selection for a specific peptide sequence. PhyloCSF scores were accordingly low (47 
